Dr Pan Pantziarka is Director of Drug Repurposing at the Anticancer Fund. Working on drug repurposing in oncology – from drug candidate identification to clinical trials to health policy work. Current projects include sarcoma clinical trials, engaging with regulators on specific repurposing projects in rare cancers and working as part of the REMEDI4ALL platform on regulatory and research funding issues.
Pan is a member of the Executive Committee of FOSTER (Fight Osteosarcoma Through European Research). He also Chairs and is the Co-founder of George Pantziarka TP53 Trust – the UK organisation for people with Li Fraumeni Syndrome. Member of the steering committee of the Bone Sarcoma Alliance – an alliance of bone sarcoma patient advocates under the Sarcoma Patient Advocacy Global Network (SPAGN) umbrella.
